Now in its tenth year, the BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies.
Who Shouldn’t Miss This Conference
- Institutional Investors
- Industry Analysts
- Senior Biotechnology Executives
Program
Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.
Why Investors Attend:
- Hear from and meet one-on-one with management from the top biotechnology companies
- Evaluate fresh investment opportunities including compatible, complementary and competitive companies
- Attend candid panel discussions with leading clinical experts and company experts on the latest therapies and technologies in development
- Get a ‘big picture’ overview of the industry and the issues affecting investments now and in the future
Why Companies Attend:
- Present company story to an audience of target investors
- Meet one-on-one with new and current investors, analysts, investment bankers and other potential corporate partners
- Hear candid panel discussions and keynotes by veteran investment and company executives
- Network with peers, investors and potential partners attending the conference
- Get the pulse on the current and proposed investment trends in biotechnology
MORE INFORMATION:
For more information:
Tracy Krughoff
Director, Events Communications / BIO
202.279.0536 (while in NY)
202.312.9274 (in DC)
tkrughoff@bio.org
0 Responses to “About”